These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 26480700

  • 1. [Interferon β].
    Matsushita T.
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():196-204. PubMed ID: 26480700
    [No Abstract] [Full Text] [Related]

  • 2. Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis.
    Gout O.
    Ann Neurol; 2008 Jan; 63(1):126; author reply 126-7. PubMed ID: 17702028
    [No Abstract] [Full Text] [Related]

  • 3. Use of interferon-beta in the treatment of multiple sclerosis.
    Derwenskus J, Lublin FD.
    Adv Neurol; 2006 Jan; 98():257-71. PubMed ID: 16400838
    [No Abstract] [Full Text] [Related]

  • 4. Interferon beta in multiple sclerosis: how much BENEFIT?
    Pittock SJ.
    Lancet; 2007 Aug 04; 370(9585):363-4. PubMed ID: 17678997
    [No Abstract] [Full Text] [Related]

  • 5. Coming of age: the use of immunomodulatory therapy in children with multiple sclerosis.
    Banwell B, Tremlett H.
    Neurology; 2005 Mar 08; 64(5):778-9. PubMed ID: 15753408
    [No Abstract] [Full Text] [Related]

  • 6. Neutralising antibodies against interferon beta in multiple sclerosis.
    Giovannoni G, Deisenhammer F.
    Lancet; 2004 Jan 10; 363(9403):166-7; author reply 168-9. PubMed ID: 14726177
    [No Abstract] [Full Text] [Related]

  • 7. Clinically isolated syndromes: predicting and delaying multiple sclerosis.
    Thrower BW.
    Neurology; 2007 Jun 12; 68(24 Suppl 4):S12-5. PubMed ID: 17562845
    [Abstract] [Full Text] [Related]

  • 8. Summary: Registry data.
    Bates D.
    Neurology; 2011 Jan 04; 76(1 Suppl 1):S39-41. PubMed ID: 21205682
    [No Abstract] [Full Text] [Related]

  • 9. Neutralising antibodies against interferon beta in multiple sclerosis.
    Mikol D.
    Lancet; 2004 Jan 10; 363(9403):167-8; author reply 168-9. PubMed ID: 14726179
    [No Abstract] [Full Text] [Related]

  • 10. Combining two multiple sclerosis treatments has no clinical benefit, study finds.
    Anekwe L.
    BMJ; 2013 Mar 14; 346():f1719. PubMed ID: 23491460
    [No Abstract] [Full Text] [Related]

  • 11. Is it time to consider rationalizing IFN-beta treatment in individuals with multiple sclerosis?
    Giovannoni G.
    J Neurol Neurosurg Psychiatry; 2004 Sep 14; 75(9):1234. PubMed ID: 15314107
    [No Abstract] [Full Text] [Related]

  • 12. Interferon beta-1b.
    Rudge P.
    Lancet; 1994 Nov 26; 344(8935):1511. PubMed ID: 7968150
    [No Abstract] [Full Text] [Related]

  • 13. Glatiramer and suspected multiple sclerosis. No proven advantage.
    Prescrire Int; 2010 Aug 26; 19(108):160. PubMed ID: 20941852
    [No Abstract] [Full Text] [Related]

  • 14. Corticosteroids in combination therapy for multiple sclerosis.
    Cohen JA.
    Lancet Neurol; 2009 Jun 26; 8(6):502-3. PubMed ID: 19409855
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacologic management of multiple sclerosis.
    Blasier MG.
    Urol Nurs; 2008 Jun 26; 28(3):217-9. PubMed ID: 18605517
    [No Abstract] [Full Text] [Related]

  • 16. Interferon-beta for multiple sclerosis: Long-term benefits?
    Rudick RA, Cutter G.
    Ann Neurol; 2007 Apr 26; 61(4):283-5. PubMed ID: 17444503
    [No Abstract] [Full Text] [Related]

  • 17. Interferon-beta 1b: new hope for multiple sclerosis.
    Holdcroft C.
    Nurse Pract; 1994 Jan 26; 19(1):6. PubMed ID: 8139804
    [No Abstract] [Full Text] [Related]

  • 18. Interferon beta for treatment of multiple sclerosis.
    Wilson BA.
    Medsurg Nurs; 1995 Apr 26; 4(2):151-3. PubMed ID: 7711824
    [No Abstract] [Full Text] [Related]

  • 19. [Magnetic resonance angiography in multiple sclerosis].
    Pati DV, Vorobeĭchik G.
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999 Apr 26; 99(12):53-7. PubMed ID: 10629934
    [No Abstract] [Full Text] [Related]

  • 20. Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study.
    Shirani A, Zhao Y, Karim ME, Petkau J, Gustafson P, Evans C, Kingwell E, van der Kop ML, Oger J, Tremlett H.
    Eur J Neurol; 2014 Jun 26; 21(6):835-44. PubMed ID: 24351059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.